<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31815742</article-id>
<article-id pub-id-type="pmc">6934221</article-id>
<article-id pub-id-type="publisher-id">124332</article-id>
<article-id pub-id-type="doi">10.1172/JCI124332</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2618-1116</contrib-id>
<name>
<surname>Uribe-Herranz</surname>
<given-names>Mireia</given-names>
</name>
<email>mireiau@upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rafail</surname>
<given-names>Stavros</given-names>
</name>
<email>psil@hotmail.com</email>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beghi</surname>
<given-names>Silvia</given-names>
</name>
<email>silvia.beghi@pennmedicine.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gil-de-Gómez</surname>
<given-names>Luis</given-names>
</name>
<email>luisgdegomez@hotmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verginadis</surname>
<given-names>Ioannis</given-names>
</name>
<email>vioannis@mail.med.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bittinger</surname>
<given-names>Kyle</given-names>
</name>
<email>kylebittinger@gmail.com</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0977-1640</contrib-id>
<name>
<surname>Pustylnikov</surname>
<given-names>Sergey</given-names>
</name>
<email>sergei.pustylnikov@uphs.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pierini</surname>
<given-names>Stefano</given-names>
</name>
<email>Stefano.Pierini@uphs.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Perales-Linares</surname>
<given-names>Renzo</given-names>
</name>
<email>renzo.peraleslinares@pennmedicine.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blair</surname>
<given-names>Ian A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mesaros</surname>
<given-names>Clementina A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snyder</surname>
<given-names>Nathaniel W.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bushman</surname>
<given-names>Frederic</given-names>
</name>
<email>bushman@mail.med.upenn.edu</email>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koumenis</surname>
<given-names>Constantinos</given-names>
</name>
<email>koumenis@xrt.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Facciabene</surname>
<given-names>Andrea</given-names>
</name>
<email>facciabe@pennmedicine.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Radiation Oncology and</aff>
<aff id="A2"><label>2</label>Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A3"><label>3</label>Division of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A4"><label>4</label>Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A5"><label>5</label>AJ Drexel Autism Institute, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A6"><label>6</label>Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Andrea Facciabene or Constantinos Koumenis, University of Pennsylvania, Department of Radiation Oncology, 3400 Civic Center Boulevard, 19104, Philadelphia, Pennsylvania, USA. Phone: 215.746.7071; Email: <email>facciabe@pennmedicine.upenn.edu</email> (AF); Phone: 215.898.0076; Email: <email>koumenis@upenn.edu</email> (CK).</corresp>
<fn>
<p><bold>Authorship note:</bold> MUH, SR, SB, and LGDG are co–first authors.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-12-09T16:00:00-0500" publication-format="electronic">
<day>9</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2019-12-09T16:00:00-0500" publication-format="electronic">
<day>9</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date date-type="pub" iso-8601-date="2020-01-02T16:00:00-0500" publication-format="print">
<day>2</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>4</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 3 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>130</volume>
<issue>1</issue>
<fpage>466</fpage>
<lpage>479</lpage>
<history>
<date date-type="received">
<day>4</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 American Society for Clinical Investigation</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://www.jci.org/articles/view/124332">This article is available online at https://www.jci.org/articles/view/124332</self-uri>
<abstract>
<p>Alterations in gut microbiota impact the pathophysiology of several diseases, including cancer. Radiotherapy (RT), an established curative and palliative cancer treatment, exerts potent immune modulatory effects, inducing tumor-associated antigen (TAA) cross-priming with antitumor CD8<sup>+</sup> T cell elicitation and abscopal effects. We tested whether the gut microbiota modulates antitumor immune response following RT distal to the gut. Vancomycin, an antibiotic that acts mainly on gram-positive bacteria and is restricted to the gut, potentiated the RT-induced antitumor immune response and tumor growth inhibition. This synergy was dependent on TAA cross presentation to cytolytic CD8<sup>+</sup> T cells and on IFN-γ. Notably, butyrate, a metabolite produced by the vancomycin-depleted gut bacteria, abrogated the vancomycin effect. In conclusion, depletion of vancomycin-sensitive bacteria enhances the antitumor activity of RT, which has important clinical ramifications.</p>
</abstract>
<abstract abstract-type="graphical">
<p>
<graphic orientation="portrait" position="float" xlink:href="jci-130-124332-g305.jpg"></graphic>
</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Immunology</kwd>
<kwd>Oncology</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Antigen presentation</kwd>
<kwd>Dendritic cells</kwd>
<kwd>Radiation therapy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>